A 55-year-old man with type 2 diabetes presents for his annual review. His HbA1c is 62 mmol/mol despite metformin 1g BD. His eGFR is 65 mL/min/1.73m$^...

Question

A 55-year-old man with type 2 diabetes presents for his annual review. His HbA1c is 62 mmol/mol despite metformin 1g BD. His eGFR is 65 mL/min/1.73m$^2$ and he has no history of cardiovascular disease. According to NICE NG28, what is the most appropriate second-line agent to add?

Accepted Answer

Empagliflozin

Answer

Gliclazide

Answer

Pioglitazone

Answer

Sitagliptin

Answer

Insulin

ukmla MCQ (SBA): Type 2 Diabetes Mellitus

A 55-year-old man with type 2 diabetes presents for his annual review. His HbA1c is 62 mmol/mol despite metformin 1g BD. His eGFR is 65 mL/min/1.73m$^2$ and he has no history of cardiovascular disease. According to NICE NG28, what is the most appropriate second-line agent to add?